RELX · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is RELX PLC (RELX) stock moving?
RELX closed at 39.91 on Nov 10, about 1.7% below the 40.62 close on Oct 22, and it has traded between 38.73 and 41.45 over the last 30 days. The sharpest move came on Nov 4 to Nov 5, when the stock rose to a 41.45 close on 3.6M shares. It then gave back those gains on falling volume, closing at 40.17 on Nov 6 and around 39.9 by Nov 10 on 1.58M shares, which suggests fading momentum. The main fundamental news is the Oct 22 trading update: underlying revenue growth of +7% year to date, with Legal +10%, Risk +8% and STM +6%. RELX reaffirmed its full-year outlook and expects adjusted operating profit growth to exceed revenue growth. Bernstein raised its price target and kept an Outperform rating on Oct 28. The company is also buying back its own shares, with 697,106 bought for about £20.68 million in the week of Oct 26 to Oct 30, which adds steady demand. The product news (Know Your Agent, Accurint One, the Elsevier report) is incremental and not quantified, and the block share admission is routine. The data gives no quarterly figures or new guidance numbers, and the price is now below its late-October level, so the near-term view is balanced while the medium-term view leans positive.
News behind the analysis
- TRADING UPDATE October 2026RELX reported underlying revenue growth of +7% year to date for the first nine months of 2026 and reaffirmed its full-year outlook, including adjusted operating profit growth above revenue growth. Legal grew +10%, Risk +8% and STM +6%.
- Bernstein Raises RELX Price Target, Maintains Outperform RatingBernstein Research raised its price target for RELX while keeping an 'Outperform' rating on the stock.
- RELX PLC Announces Share Repurchase Program UpdateRELX repurchased 697,106 ordinary shares between October 26 and October 30, 2026, for a total consideration of about £20.68 million.
- LexisNexis Risk Solutions Launches Accurint One for Law EnforcementLexisNexis Risk Solutions introduced Accurint One, a platform that combines data, analytics and AI for law enforcement investigations.
- Elsevier and Research4Life Publish Report on Research Participation in Low- and Middle-Income CountriesElsevier, a RELX subsidiary, released a report on the funding and publishing challenges faced by researchers in low- and middle-income countries.
- LexisNexis Risk Solutions Introduces 'Know Your Agent' IntelligenceLexisNexis Risk Solutions launched a tool to help government agencies identify and manage risks linked to AI agents.
- RELX PLC Announces Block Admission of Ordinary SharesRELX filed for the block admission of 60,000 ordinary shares, a routine administrative step.
- RELX PLC Announces Total Voting RightsRELX updated its total voting rights after changes to its issued share capital and treasury holdings. The filing reports 1,743,014,323 shares in issue, excluding treasury shares, in an earlier SEC filing.
About RELX PLC
RELX is a UK-based global provider of data, analytics and decision tools for professional and business customers, with its ADR traded on the NYSE. It is known for brands such as LexisNexis (legal and risk) and Elsevier (scientific publishing), and most of its revenue comes from subscriptions and repeat use. Its adjusted operating margin is high, around 35% in the first half of 2026.
How it makes money
RELX has four segments. Risk (LexisNexis Risk Solutions) sells fraud, identity and credit-risk analytics and brings in roughly a third of revenue. Scientific, Technical & Medical (Elsevier) sells journals, databases and research tools, also about a third. Legal (LexisNexis Legal & Professional) sells legal research and AI-assisted tools, about a fifth. Exhibitions (RX) runs trade shows, roughly a sixth. Total revenue was about £9.6bn in 2025. In the first half of 2026 revenue was about £4.9bn, with roughly 7% underlying growth.
What usually moves RELX
- Adoption of generative AI legal and research tools, and fears that AI could disrupt its business
- Subscription renewals and growth in Risk analytics transaction volumes
- Academic and government research funding
- Trade show attendance and the business cycle
- GBP/USD exchange rate and share buybacks